维普中文期刊产品整合服务
11篇 您的检索式:作者名="Verd E F"
    题名 作者 年代 出处 被引量
1Modulatory effects of estrogen in two murine models of experimental colitis显示文摘Verd E F Deng Y Bercik P Collins S M 2002Am J Physiol Gastrointest Liver Physiol2002,283,:1
2The high-quality draft genome of peach (Prunus persica) identifies unique patterns of genetic diversity,domestication and genome evolution显示文摘The International Peach Genome Iniative Verde I Abbott A G Scalabrin S Jung S Shu S Marroni F Zhebentyayeva T Dettori M T Grimwood J Cattonaro F Zuccolo A Rossini L Jenkins J Vendramin E Meisel L A Decroocq V Sosinski B Prochnik S Mitros T Policriti A Cip 0,,:1
3Control of microtubule dynamics and length by cyclin A-and cyclin B-dependent kinase in Xenopus egg extracts显示文摘Verde F Dogterom M Stelzer E 1992Cell Biol J1992,118,:1
4Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction显示文摘Bercík P Wang L Verdú E F 2004Gastroenterology2004,127,:1
5Renal biopsy in very elderly patients :data from the Spanish Registry of Glomerulonephritis 显示文摘Verde E Quiroga B Rivera F 2012Am J Nephrol2012,35,:1
6Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gutdysfunction显示文摘Bercìk P Wang L Verdú E F 2004Gastroenterology2004,127,:1
7Control of microtubule dynamics and length by cyclin A-and cyclin B-dependent kinases in Xenopus egg extracts显示文摘Verde F Dogterom M Stelzer E 1992Cell Biol1992,118,:1
8Sequential protocol with urinary-FSH/recombinant-FSH versus standard protocol with recombinant-FSH in women of advanced age undergoing IVF 显示文摘Colacurci N Caprio F La Verde E 2014Gynecol Endocrinol2014,30,10:1
9Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction 显示文摘VERDE F BERC K P BERGONZELLI G E 2004Gastroenterology2004,127,:1
10Urinary clusterin,cystatin C,beta2-microglobulin and total protein as markers to detect drug-induced kidney injury显示文摘Dieterle F Perentes E Cordier A Roth DR Verdes P Grenet O 2010Nat Biotechnol2010,28,5:1
11Effect of Aspergillus niger prolyl endopeptidase in patients with celiac disease on a long-term gluten-free diet显示文摘BACKGROUND The gluten-free diet(GFD)has limitations,and there is intense research in the development of adjuvant therapies.AIM To examine the effects of orally administered Aspergillus niger prolyl endopeptidase protease(AN-PEP)on inadvertent gluten exposure and symptom prevention in adult celiac disease(CeD)patients following their usual GFD.METHODS This was an exploratory,double-blind,randomized,placebo-controlled trial that enrolled CeD patients on a long-term GFD.After a 4-wk run-in period,patients were randomized to 4 wk of two AN-PEP capsules(GliadinX;AVI Research,LLC,United States)at each of three meals per day or placebo.Outcome endpoints were:(1)Average weekly stool gluten immunogenic peptides(GIP)between the run-in and end of treatments and between AN-PEP and placebo;(2)celiac symptom index(CSI);(3)CeD-specific serology;and(4)quality of life.Stool samples were collected for GIP testing by ELISA every Tuesday and Friday during run-ins and treatments.RESULTS Forty patients were randomized for the intention-to-treat analysis,and three were excluded from the per-protocol assessment.Overall,628/640(98.1%)stool samples were collected.GIP was undetectable(<0.08μg/g)in 65.6%of samples,and no differences between treatment arms were detected.Only 0.5%of samples had GIP concentrations sufficiently high(>0.32μg/g)to potentially cause mucosal damage.Median GIP concentration in the AN-PEP arm was 44.7%lower than in the run-in period.One-third of patients exhibiting GIP>0.08μg/g during run-in had lower or undetectable GIP after AN-PEP treatment.Compared with the run-in period,the proportion of symptomatic patients(CSI>38)in the AN-PEP arm was significantly lower(P<0.03).AN-PEP did not result in changes in specific serologies.CONCLUSION This exploratory study conducted in a real-life setting revealed high adherence to the GFD.The AN-PEP treatment did not significantly reduce the overall GIP stool concentration.However,given the observation of a significantly lower prevalence of patients with severe symptoms in the AN-PEP arm,further clinical research is warranted.Juan Pablo Stefanolo Verónica Segura Martina Grizzuti Abel Heredia Isabel Comino Ana Florencia Costa Roberto Puebla María Paz Temprano Sonia Isabel Niveloni Gabriel de Diego María E Oregui Edgardo Gustavo Smecuol Mauricio C de Marzi Elena F Verdú Carolina Sousa Julio César Bai 2024World Journal of Gastroenterology2024,30,11:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费